Failure of IGF-I and IGFBP-3 to diagnose growth hormone insufficiency

BACKGROUND Growth hormone insufficiency (GHI) is diagnosed conventionally by short stature and slow growth, and is confirmed by diminished peak GH response to a provocation test. Insulin-like growth factor I (IGF-I) and IGF binding protein 3 (IGFBP-3) have previously been considered individually OBJECTIVE To test the hypothesis that the combined analysis of IGF-I and IGFBP-3 could act as a surrogate marker for the diagnosis of GHI. DESIGN Reference ranges for IGF-I and IGFBP-3 were calculated using 521 normal individuals. A retrospective analysis was performed on 318 children referred for investigation of short stature. RESULTS No significant difference was found between either the IGF-I or IGFBP-3 standard deviation scores (SDSs) in children with and without GHI. If the requirement were for both tests to be positive (< −2 SDS) for a diagnosis of GHI, then 99% of children without GHI would be correctly identified; however, the sensitivity of the test was only 15%. CONCLUSIONS Neither IGF-I nor IGFBP-3 alone is a marker for GHI. In addition, they cannot be used as an effective screening test in combination.

[1]  J. Wit,et al.  Plasma Levels of Insulin-Like Growth Factor (IGF)-I, IGF-II and IGF-Binding Protein-3 in the Evaluation of Childhood Growth Hormone Deficiency , 1998, Hormone Research in Paediatrics.

[2]  K. Michaelsen,et al.  Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. , 1997, The Journal of clinical endocrinology and metabolism.

[3]  G. Addison,et al.  Urinary IGF and IGF binding protein‐3 in children with disordered growth , 1997, Clinical endocrinology.

[4]  V. Tillmann,et al.  Biochemical Tests in the Diagnosis of Childhood Growth Hormone Deficiency , 1997 .

[5]  V. Tillmann,et al.  Biochemical tests in the diagnosis of childhood growth hormone deficiency. , 1997, The Journal of clinical endocrinology and metabolism.

[6]  R. Rasat,et al.  IGF-1 and IGFBP-3 screening for disorders of growth hormone secretion. , 1996, The New Zealand medical journal.

[7]  H C Sox,et al.  The evaluation of diagnostic tests: principles, problems, and new developments. , 1996, Annual review of medicine.

[8]  M. Cappa,et al.  Is IGF binding protein‐3 assessment helpful for the diagnosis of GH deficiency? , 1995, Clinical endocrinology.

[9]  A E Ades,et al.  Age-related reference ranges: significance tests for models and confidence intervals for centiles. , 1994, Statistics in medicine.

[10]  D. Harris,et al.  Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. , 1994, The Journal of pediatrics.

[11]  L. Breum,et al.  The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone. , 1994, Metabolism: clinical and experimental.

[12]  J. Souberbielle,et al.  Diagnostic markers of permanent idiopathic growth hormone deficiency. , 1994, The Journal of clinical endocrinology and metabolism.

[13]  M. Ranke,et al.  Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. , 1993, The Journal of clinical endocrinology and metabolism.

[14]  R. Baxter.  Circulating binding proteins for the insulinlike growth factors , 1993, Trends in Endocrinology & Metabolism.

[15]  M. Dattani,et al.  What is a normal stimulated growth hormone concentration? , 1992, The Journal of endocrinology.

[16]  P. Hindmarsh,et al.  Performance of proficiency survey samples in two immunoradiometric assays of human growth hormone and comparison with patients' samples. , 1992, Clinical chemistry.

[17]  Y. Hasegawa,et al.  Western ligand blot assay for human growth hormone-dependent insulin-like growth factor binding protein (IGFBP-3): the serum levels in patients with classical growth hormone deficiency. , 1992, Endocrinologia japonica.

[18]  R. Stanhope,et al.  Hazards of pharmacological tests of growth hormone secretion in childhood. , 1992, BMJ.

[19]  H. Zeisel,et al.  A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. , 1990, The Journal of clinical endocrinology and metabolism.

[20]  T. Cole.  The LMS method for constructing normalized growth standards. , 1990, European journal of clinical nutrition.

[21]  R. Baxter,et al.  Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labeling. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D. Wilson,et al.  Insulin-like growth factors I and II in evaluation of growth retardation. , 1986, The Journal of pediatrics.

[23]  H C Sox,et al.  Probability theory in the use of diagnostic tests. An introduction to critical study of the literature. , 1986, Annals of internal medicine.

[24]  D. Sackett,et al.  The Ends of Human Life: Medical Ethics in a Liberal Polity , 1992, Annals of Internal Medicine.

[25]  D. Clemmons,et al.  Dietary components that regulate serum somatomedin-C concentrations in humans. , 1983, The Journal of clinical investigation.

[26]  R. Furlanetto,et al.  Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. , 1977, The Journal of clinical investigation.